Loading…
Reported covered position: Senator Conrad Staff
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medicare Orthotics and Prosthetics Improvement Act of 2009
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Prosthetic and Custom Orthotic Parity Act of 2009
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2010 · second_quarter · 2A
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
| STATE OF THE USA |
| 5 |
| 2009–2010 |
| ALEXION PHARMACEUTICALS, INC. | 4 | 2009–2010 |
| CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND | 4 | 2010 |
| NATIONAL VENTURE CAPITAL ASSOCIATION | 4 | 2009–2010 |
| AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION | 3 | 2009–2010 |
| AMGEN | 3 | 2009–2010 |
| EISAI CORPORATION OF NORTH AMERICA | 3 | 2009 |
| SUSAN G KOMEN FOR THE CURE | 3 | 2010 |
| ABBOTT LABORATORIES | 2 | 2010 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2 | 2010 |
| XDX INC | 1 | 2010 |
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Genomics and Personalized Medicine Act of 2010
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Genomics and Personalized Medicine Act of 2010
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory- developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act H.R. 3590
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Prosthetics and Custom Orthotics Parity Act of 2010
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
American Middle Class Tax (AMT) Relief Act of 2007
Client: CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patient Protection and Affordable Care Act- HR 3590 Medicare Coveratge and Reimbursement Issue
American Middle Class Tax (AMT) Relief Act of 2007
Client: CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory- developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: BECTON DICKINSON AND COMPANY · Firm: FOLEY HOAG LLP
Federal policies and legislations regarding utilization of diagnostic products and medical equipment, hospital acquired infections; Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: BECTON DICKINSON AND COMPANY · Firm: FOLEY HOAG LLP
Federal policies and legislations regarding utilization of diagnostic products and medical equipment, hospital acquired infections; Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Health Insurance Coverage Protection Act
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Health Insurance Coverage Protection Act- S. 442, H.R. 1085 Comparative Effectiveness Research- H.R. 2502, S. 1213, H.R. 1 Social Security compassionate allowances program; Follow-on Biologics- H.R. 1427, H.R. 1548; Orphan drug policy
Health Insurance Coverage Protection Act
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962; Health Insurance Coverage Protection Act - S.442, H.R.1085 Comparative Effectiveness Research - H.R.2502, S.1213, H.R.1 Follow-on Biologics - H.R.1427, H.R.1548; Social Security compassionate allowances program; Orphan drug policy
Patent Reform Act of 2009
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962, S.1695; Patent Reform - S.515, H.R.1260 Health reform and Medicare payments
Patent Reform Act of 2009
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: FOLEY HOAG LLP
Follow-on Biologics - H.R.1427, H.R.1548, S.1695; Patent Reform - S.515, H.R.1260 Health reform and Medicare payments
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962 Biosimilars Follow-on Biologics - Promoting Innovation and Access to Life-Saving Medicine - H.R.1427 Pathway for Biosimilars Act- H.R.1548; Biologics Price Competition and Innovation Act of 2007- S.1695
Promoting Innovation and Access to Life-Saving Medicine Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Health Insurance Coverage Protection Act- S. 442, H.R. 1085 Comparative Effectiveness Research- H.R. 2502, S. 1213, H.R. 1 Social Security compassionate allowances program; Follow-on Biologics- H.R. 1427, H.R. 1548; Orphan drug policy
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962; Health Insurance Coverage Protection Act - S.442, H.R.1085 Comparative Effectiveness Research - H.R.2502, S.1213, H.R.1 Follow-on Biologics - H.R.1427, H.R.1548; Social Security compassionate allowances program; Orphan drug policy
Promoting Innovation and Access to Life-Saving Medicine Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: FOLEY HOAG LLP
Follow-on Biologics - H.R.1427, H.R.1548, S.1695; Patent Reform - S.515, H.R.1260 Health reform and Medicare payments
Promoting Innovation and Access to Life-Saving Medicine Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200; Pathway for Biosimilars Act of 2009 H.R.1548, Promoting Innovation and Access to Life-saving Medicines Act H.R.1427; Patient-Centered Outcomes Research Act S.1213.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills. Biosimilars: HR 1548- Pathway for Biosimilars Act of 2009, HR 1427- Promoting Innovation and Access to Life-saving Medicines Act.. Comparative effectiveness research: S. 1213, The Patient-Centered Outcomes Research Act; H.R. 2502, The Comparative Effectiveness Research Act
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Health Insurance Coverage Protection Act- S. 442, H.R. 1085 Comparative Effectiveness Research- H.R. 2502, S. 1213, H.R. 1 Social Security compassionate allowances program; Follow-on Biologics- H.R. 1427, H.R. 1548; Orphan drug policy
Pathway for Biosimilars Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills. Biosimilars: HR 1548- Pathway for Biosimilars Act of 2009, HR 1427- Promoting Innovation and Access to Life-saving Medicines Act.. Comparative effectiveness research: S. 1213, The Patient-Centered Outcomes Research Act; H.R. 2502, The Comparative Effectiveness Research Act
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962 Biosimilars Follow-on Biologics - Promoting Innovation and Access to Life-Saving Medicine - H.R.1427 Pathway for Biosimilars Act- H.R.1548; Biologics Price Competition and Innovation Act of 2007- S.1695
Pathway for Biosimilars Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.
Pathway for Biosimilars Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: FOLEY HOAG LLP
Follow-on Biologics - H.R.1427, H.R.1548, S.1695; Patent Reform - S.515, H.R.1260 Health reform and Medicare payments
Pathway for Biosimilars Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200; Pathway for Biosimilars Act of 2009 H.R.1548, Promoting Innovation and Access to Life-saving Medicines Act H.R.1427; Patient-Centered Outcomes Research Act S.1213.
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962; Health Insurance Coverage Protection Act - S.442, H.R.1085 Comparative Effectiveness Research - H.R.2502, S.1213, H.R.1 Follow-on Biologics - H.R.1427, H.R.1548; Social Security compassionate allowances program; Orphan drug policy
Comparative Effectiveness Research Act of 2009
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Comparative Effectiveness Research Act of 2009
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Comparative Effectiveness Research Act of 2009
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Health Insurance Coverage Protection Act- S. 442, H.R. 1085 Comparative Effectiveness Research- H.R. 2502, S. 1213, H.R. 1 Social Security compassionate allowances program; Follow-on Biologics- H.R. 1427, H.R. 1548; Orphan drug policy
Comparative Effectiveness Research Act of 2009
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
S. 1213, The Patient-Centered Outcomes Research Act H.R. 2502, The Comparative Effectiveness Research Act
Comparative Effectiveness Research Act of 2009
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills. Biosimilars: HR 1548- Pathway for Biosimilars Act of 2009, HR 1427- Promoting Innovation and Access to Life-saving Medicines Act.. Comparative effectiveness research: S. 1213, The Patient-Centered Outcomes Research Act; H.R. 2502, The Comparative Effectiveness Research Act
Comparative Effectiveness Research Act of 2009
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Comparative Effectiveness Research Act of 2009
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962; Health Insurance Coverage Protection Act - S.442, H.R.1085 Comparative Effectiveness Research - H.R.2502, S.1213, H.R.1 Follow-on Biologics - H.R.1427, H.R.1548; Social Security compassionate allowances program; Orphan drug policy
Comparative Effectiveness Research Act of 2009
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act; Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2502 ;Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Reaching Rural Veterans through Telehealth Act
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Reaching Rural Veterans through Telehealth Act
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Reaching Rural Veterans through Telehealth Act
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Reaching Rural Veterans through Telehealth Act
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505 S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200
Reaching Rural Veterans through Telehealth Act
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
America's Affordable Health Choices Act of 2009
Client: INVERNESS MEDICAL INNOVATIONS · Firm: FOLEY HOAG LLP
HR 3200 Affordable Health Choices Act S.__ Affordable Health Choices Act "Senior Planning and Navigation Act" S 1263 Health Care Reform
America's Affordable Health Choices Act of 2009
Client: INVERNESS MEDICAL INNOVATIONS · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Prevention and wellness provisions
America's Affordable Health Choices Act of 2009
Client: INVERNESS MEDICAL INNOVATIONS · Firm: FOLEY HOAG LLP
HR 3200 Affordable Health Choices Act S.__ Affordable Health Choices Act "Senior Planning and Navigation Act" S 1263 Health Care Reform
America's Affordable Health Choices Act of 2009
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
America's Affordable Health Choices Act of 2009
Client: INVERNESS MEDICAL INNOVATIONS · Firm: FOLEY HOAG LLP
HR 3200 Affordable Health Choices Act S.__ Affordable Health Choices Act "Senior Planning and Navigation Act" S 1263 Health Care Reform
America's Affordable Health Choices Act of 2009
Client: INVERNESS MEDICAL INNOVATIONS · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Prevention and wellness provisions
America's Affordable Health Choices Act of 2009
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200; Pathway for Biosimilars Act of 2009 H.R.1548, Promoting Innovation and Access to Life-saving Medicines Act H.R.1427; Patient-Centered Outcomes Research Act S.1213.
America's Affordable Health Choices Act of 2009
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Health Insurance Coverage Protection Act- S. 442, H.R. 1085 Comparative Effectiveness Research- H.R. 2502, S. 1213, H.R. 1 Social Security compassionate allowances program; Follow-on Biologics- H.R. 1427, H.R. 1548; Orphan drug policy
America's Affordable Health Choices Act of 2009
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505 S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200
America's Affordable Health Choices Act of 2009
Client: INVERNESS MEDICAL INNOVATIONS · Firm: FOLEY HOAG LLP
HR 3200 Affordable Health Choices Act S.__ Affordable Health Choices Act "Senior Planning and Navigation Act" S 1263 Health Care Reform
America's Affordable Health Choices Act of 2009
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Food and Drug Administration Globalization Act of 2009
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR759 Medicare Improvement Patients and Providers Act - HR 6331
Food and Drug Administration Globalization Act of 2009
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests - S.736, Laboratory Test Improvement Act - S.976; FDA Globalization Act - H.R.759; Medicare Improvement Patients and Providers Act - H.R.6331; Patient Access to Critical Lab Tests Act - S.1220 Geonomics and Personalized Medicare Act
Food and Drug Administration Globalization Act of 2009
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests S.736; Laboratory Test Improvement Act S.976; Genomics and Personalized Medicare Act; FDA Globalization Act H.R.759; Medicare Improvement Patients and Providers Act H.R. 6331; Patient Access to Critical Lab Tests Act S. 1220
Patient-Centered Outcomes Research Act of 2009
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act; Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2502 ;Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Patient-Centered Outcomes Research Act of 2009
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Patient-Centered Outcomes Research Act of 2009
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962; Health Insurance Coverage Protection Act - S.442, H.R.1085 Comparative Effectiveness Research - H.R.2502, S.1213, H.R.1 Follow-on Biologics - H.R.1427, H.R.1548; Social Security compassionate allowances program; Orphan drug policy
Patient-Centered Outcomes Research Act of 2009
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Patient-Centered Outcomes Research Act of 2009
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills. Biosimilars: HR 1548- Pathway for Biosimilars Act of 2009, HR 1427- Promoting Innovation and Access to Life-saving Medicines Act.. Comparative effectiveness research: S. 1213, The Patient-Centered Outcomes Research Act; H.R. 2502, The Comparative Effectiveness Research Act
Patient-Centered Outcomes Research Act of 2009
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505 S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Patient-Centered Outcomes Research Act of 2009
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.
S. 1213, The Patient-Centered Outcomes Research Act H.R. 2502, The Comparative Effectiveness Research Act
Patient-Centered Outcomes Research Act of 2009
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200; Pathway for Biosimilars Act of 2009 H.R.1548, Promoting Innovation and Access to Life-saving Medicines Act H.R.1427; Patient-Centered Outcomes Research Act S.1213.
Patient-Centered Outcomes Research Act of 2009
Client: ALEXION PHARMACEUTICALS, INC. · Firm: FOLEY HOAG LLP
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Health Insurance Coverage Protection Act- S. 442, H.R. 1085 Comparative Effectiveness Research- H.R. 2502, S. 1213, H.R. 1 Social Security compassionate allowances program; Follow-on Biologics- H.R. 1427, H.R. 1548; Orphan drug policy
Patient-Centered Outcomes Research Act of 2009
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
2010 · first_quarter · 1A
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
STATE OF THE USA via FOLEY HOAG LLP
2010 · second_quarter · Q2
Create a set of key national indicators Patient Protection and Affordable Care Act (P.L. 111-148) (Section 5605)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2010 · second_quarter · Q2
Medicare and Medicaid issues associated with the Patient Protection and Affordable Care Act of 2010, H.R. 3590 American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES
GLAXOSMITHKLINE via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND via FOLEY HOAG LLP
2010 · second_quarter · Q2
Medicare and Medicaid coverage and reimbursement issues Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) Meeting with Health Resources & Services Administration regarding Federally Qualified Health Centers designation
Filing targets: HOUSE OF REPRESENTATIVES
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2010 · second_quarter · Q2
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) (End Stage Renal Disease)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2010 · second_quarter · Q2
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL VENTURE CAPITAL ASSOCIATION via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patent Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2010 · second_quarter · Q2
Colorectal cancer Medicare and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Medicare and Medicaid coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND via FOLEY HOAG LLP
2010 · first_quarter · Q1
Medicare and Medicaid coverage and reimbursement issues
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Q1
Medicare payment for molecular diagnostics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STATE OF THE USA via FOLEY HOAG LLP
2010 · first_quarter · Q1
Create a set of key national indicators
Filing targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL VENTURE CAPITAL ASSOCIATION via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2010 · first_quarter · Q1
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2010 · first_quarter · Q1
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory- developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act H.R. 3590
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2010 · first_quarter · Q1
Matters relating to healthcare associated infections.
Federal policies and legislations regarding utilization of diagnostic products and medical equipment, hospital acquired infections; Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act- HR 3590 Medicare Coveratge and Reimbursement Issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2010 · first_quarter · Q1
Colorectal cancer Medicare and reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND via FOLEY HOAG LLP
2010 · first_quarter · RR
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · 2@
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2009 · fourth_quarter · 4@
Matters relating to healthcare associated infections
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · 2A
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2009 · fourth_quarter · 4A
Matters relating to healthcare associated infections
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · fourth_quarter · 4A
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · 3A
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
STATE OF THE USA via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Create a set of key national indicators
Filing targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
American Recovery and Reinvestment Act; Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2502 ;Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL VENTURE CAPITAL ASSOCIATION via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962, S.1695; Patent Reform - S.515, H.R.1260 Health reform and Medicare payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVERNESS MEDICAL INNOVATIONS via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Prevention and wellness provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.
Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515
Medicare and Medicaid coverage and reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS)
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests - S.736, Laboratory Test Improvement Act - S.976; FDA Globalization Act - H.R.759; Medicare Improvement Patients and Providers Act - H.R.6331; Patient Access to Critical Lab Tests Act - S.1220 Geonomics and Personalized Medicare Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Group Health Plan Prosthetics Parity Act of 2007 - H.R.5615 Medicare Orthotics and Prosthetics Improvement Act of 2008 - H.R.6878
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962 Biosimilars Follow-on Biologics - Promoting Innovation and Access to Life-Saving Medicine - H.R.1427 Pathway for Biosimilars Act- H.R.1548; Biologics Price Competition and Innovation Act of 2007- S.1695
Patient Protection and Affordable Care Act - H.R.3590 Medicare coverage and reimbursement Medicaid Drug Rebate Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Colorectal cancer Medicare coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962; Health Insurance Coverage Protection Act - S.442, H.R.1085 Comparative Effectiveness Research - H.R.2502, S.1213, H.R.1 Follow-on Biologics - H.R.1427, H.R.1548; Social Security compassionate allowances program; Orphan drug policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Matters relating to healthcare associated infections
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL VENTURE CAPITAL ASSOCIATION via FOLEY HOAG LLP
2009 · third_quarter · Q3
Follow-on Biologics - H.R.1427, H.R.1548, S.1695; Patent Reform - S.515, H.R.1260 Health reform and Medicare payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Health Insurance Coverage Protection Act- S. 442, H.R. 1085 Comparative Effectiveness Research- H.R. 2502, S. 1213, H.R. 1 Social Security compassionate allowances program; Follow-on Biologics- H.R. 1427, H.R. 1548; Orphan drug policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVERNESS MEDICAL INNOVATIONS via FOLEY HOAG LLP
2009 · third_quarter · 3A
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Prevention and wellness provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVERNESS MEDICAL INNOVATIONS via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Prevention and wellness provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2009 · third_quarter · Q3
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections
Matters relating to healthcare associated infections
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2009 · third_quarter · Q3
Colorectal cancer Medicare coverage and reimbursement issues
S.___ Americas Healthy Futures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · third_quarter · Q3
Medicare and Medicaid coverage and reimbursement issues
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200; Pathway for Biosimilars Act of 2009 H.R.1548, Promoting Innovation and Access to Life-saving Medicines Act H.R.1427; Patient-Centered Outcomes Research Act S.1213.
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S.515
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · third_quarter · Q3
American Recovery and Reinvestment Act Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505 S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
STATE OF THE USA via FOLEY HOAG LLP
2009 · third_quarter · Q3
Create a set of key national indicators
Filing targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2009 · third_quarter · Q3
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests S.736; Laboratory Test Improvement Act S.976; Genomics and Personalized Medicare Act; FDA Globalization Act H.R.759; Medicare Improvement Patients and Providers Act H.R. 6331; Patient Access to Critical Lab Tests Act S. 1220
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INVERNESS MEDICAL INNOVATIONS via FOLEY HOAG LLP
2009 · second_quarter · Q2
HR 3200 Affordable Health Choices Act S.__ Affordable Health Choices Act "Senior Planning and Navigation Act" S 1263 Health Care Reform
HR 3200 Affordable Health Choices Act S.__ Affordable Health Choices Act "Senior Planning and Navigation Act" S 1263 Health Care Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVERNESS MEDICAL INNOVATIONS via FOLEY HOAG LLP
2009 · second_quarter · RR
HR 3200 Affordable Health Choices Act S.__ Affordable Health Choices Act "Senior Planning and Navigation Act" S 1263 Health Care Reform
HR 3200 Affordable Health Choices Act S.__ Affordable Health Choices Act "Senior Planning and Navigation Act" S 1263 Health Care Reform
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2009 · second_quarter · Q2
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR759 Medicare Improvement Patients and Providers Act - HR 6331
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STATE OF THE USA via FOLEY HOAG LLP
2009 · second_quarter · Q2
Create a set of key national indicators
Filing targets: SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · second_quarter · Q2
Medicare and Medicaid coverage and reimbursement issues
Senate and House comprehensive health reform bills. Biosimilars: HR 1548- Pathway for Biosimilars Act of 2009, HR 1427- Promoting Innovation and Access to Life-saving Medicines Act.. Comparative effectiveness research: S. 1213, The Patient-Centered Outcomes Research Act; H.R. 2502, The Comparative Effectiveness Research Act
S. 515 Patent Reform Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · Q2
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2009 · second_quarter · Q2
Senate comprehensive health reform bills; colorectal cancer Medicare coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · second_quarter · Q2
S. 1213, The Patient-Centered Outcomes Research Act H.R. 2502, The Comparative Effectiveness Research Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2009 · second_quarter · Q2
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections
Matters relating to healthcare associated infections
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE